Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview

Area of Science:

• Nanotechnology and Pharmaceutical Sciences
• Endocrinology and Metabolic Diseases

Background:

• Diabetes mellitus represents a significant global health and economic challenge, characterized by increasing prevalence and high complication rates.
• Effective blood glucose control is crucial for mitigating diabetes-related complications, driving continuous research into novel therapeutic strategies.

Purpose of the Study:

• To review the fabrication, surface engineering, and toxicological profile of dendrimers.
• To highlight the application of dendrimers in the delivery of antidiabetic drugs for improved diabetes management.

Main Methods:

• Literature review focusing on dendrimer synthesis and characterization.
• Analysis of studies investigating dendrimer-based delivery systems for antidiabetic agents.
• Examination of toxicological data related to dendrimer applications.

Main Results:

• Dendrimers are well-defined, nanosized, three-dimensional structures with potential in drug delivery.
• Nanocarrier systems, including dendrimers, show promise for enhanced delivery of hypoglycemic agents.
• Dendrimer-based systems can potentially improve diabetes control with reduced side effects.

Conclusions:

• Dendrimers are versatile nanostructures with significant potential in personalized medicine and drug delivery.
• The application of dendrimers in antidiabetic drug delivery offers a promising avenue for managing diabetes effectively.
• Further research into dendrimer fabrication, surface modification, and safety is warranted for clinical translation.